BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28462075)

  • 1. Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women.
    Fanelli F; Mezzullo M; Belluomo I; Di Lallo VD; Baccini M; Ibarra Gasparini D; Casadio E; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
    Mol Metab; 2017 May; 6(5):406-415. PubMed ID: 28462075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism.
    Fanelli F; Mezzullo M; Repaci A; Belluomo I; Ibarra Gasparini D; Di Dalmazi G; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
    Mol Metab; 2018 Aug; 14():82-94. PubMed ID: 29935920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
    Di Marzo V; Verrijken A; Hakkarainen A; Petrosino S; Mertens I; Lundbom N; Piscitelli F; Westerbacka J; Soro-Paavonen A; Matias I; Van Gaal L; Taskinen MR
    Eur J Endocrinol; 2009 Nov; 161(5):715-22. PubMed ID: 19745037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors.
    Di Marzo V; Côté M; Matias I; Lemieux I; Arsenault BJ; Cartier A; Piscitelli F; Petrosino S; Alméras N; Després JP
    Diabetologia; 2009 Feb; 52(2):213-7. PubMed ID: 18972095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
    Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
    Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
    Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
    PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause.
    Tufano A; Marzo P; Enrini R; Morricone L; Caviezel F; Ambrosi B
    J Endocrinol Invest; 2004; 27(7):648-53. PubMed ID: 15505988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid profile comparison between pre- and post-menopausal women].
    Wang N; Qin MZ; Cui J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
    [No Abstract]   [Full Text] [Related]  

  • 11. Microvascular dysfunction: a direct link among BMI, waist circumference and glucose homeostasis in young overweight/obese normoglycemic women?
    Kraemer-Aguiar LG; Maranhão PA; Sicuro FL; Bouskela E
    Int J Obes (Lond); 2010 Jan; 34(1):111-7. PubMed ID: 19806157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of hyperleptinaemia in an African population.
    Njelekela M; Kuga S; Hiraoka J; Masesa Z; Ntogwisangu J; Mashalla Y; Ikeda K; Mtabaji J; Nara Y; Yamori Y; Tsuda K
    East Afr Med J; 2003 Apr; 80(4):195-9. PubMed ID: 12918802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal factor analysis reveals a distinct clustering of cardiometabolic improvements during intensive, short-term dietary and exercise intervention in obese children and adolescents.
    Hobkirk JP; King RF; Gately P; Pemberton P; Smith A; Barth JH; Carroll S
    Metab Syndr Relat Disord; 2012 Feb; 10(1):20-5. PubMed ID: 21936669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome.
    Ebron K; Andersen CJ; Aguilar D; Blesso CN; Barona J; Dugan CE; Jones JL; Al-Sarraj T; Fernandez ML
    Metab Syndr Relat Disord; 2015 Dec; 13(10):458-64. PubMed ID: 26431271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From metabolic normality to cardiometabolic risk factors in subjects with obesity.
    Bobbioni-Harsch E; Pataky Z; Makoundou V; Laville M; Disse E; Anderwald C; Konrad T; Golay A;
    Obesity (Silver Spring); 2012 Oct; 20(10):2063-9. PubMed ID: 22421925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating anandamide and blood pressure in patients with obstructive sleep apnea.
    Engeli S; Blüher M; Jumpertz R; Wiesner T; Wirtz H; Bosse-Henck A; Stumvoll M; Batkai S; Pacher P; Harvey-White J; Kunos G; Jordan J
    J Hypertens; 2012 Dec; 30(12):2345-51. PubMed ID: 23032139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].
    Wang LY; Wei L; Yu HY; Zhang Y; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):235-8. PubMed ID: 19552838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea.
    Wang X; Yu Q; Yue H; Zhang J; Zeng S; Cui F
    Biomed Res Int; 2016; 2016():9782031. PubMed ID: 26904688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.
    Al-Harithy RN; Al-Ghamdi S
    Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.